Data was included in scientific programming at the annual meeting of The Retina Society ATLANTA,…
Data was included in scientific programming at the annual meeting of The Retina Society ATLANTA,…
SAN DIEGO, Nov. 29, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
SAN DIEGO, Nov. 29, 2022 (GLOBE NEWSWIRE) — Cidara Therapeutics, Inc. (NASDAQ: CDTX), a biotechnology…
SOT106 is an antibody-drug conjugate (ADC) targeting an attractive surface antigen expressed on multiple solid…
SOT106 is an antibody-drug conjugate (ADC) targeting an attractive surface antigen expressed on multiple solid…
CTIM-76 named as lead candidate to target Claudin 6 positive cancers IND submission expected in…
CTIM-76 named as lead candidate to target Claudin 6 positive cancers IND submission expected in…
Influid Water-soluble Nanotechnology Avicanna’s Patent-Pending Influid Technology Inside Viola Water-Soluble THC Infuser Developed through Avicanna’s…
Influid Water-soluble Nanotechnology Avicanna’s Patent-Pending Influid Technology Inside Viola Water-Soluble THC Infuser Developed through Avicanna’s…
Combining 177Lu-PNT6555 with anti-PD-1 immunotherapy resulted in a significantly increased survival benefit compared to independent…
Combining 177Lu-PNT6555 with anti-PD-1 immunotherapy resulted in a significantly increased survival benefit compared to independent…
DEVON, Pa., Nov. 29, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
DEVON, Pa., Nov. 29, 2022 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
While Boundary Bay Cannabis Received Demand for Over 725,000 Grams of High-Quality Bulk Cannabis in…
While Boundary Bay Cannabis Received Demand for Over 725,000 Grams of High-Quality Bulk Cannabis in…
WAYNE, Pa. and SHANGHAI, China, Nov. 29, 2022 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ:…
WAYNE, Pa. and SHANGHAI, China, Nov. 29, 2022 (GLOBE NEWSWIRE) — Aclaris Therapeutics, Inc. (NASDAQ:…
Global Study to Evaluate Bemnifosbuvir as Monotherapy and in Combination in Non-Hospitalized Patients at High…
Global Study to Evaluate Bemnifosbuvir as Monotherapy and in Combination in Non-Hospitalized Patients at High…